Cytodyn Inc (CYDY)

[Hold10]

you keep proving me right.
i agree that FDA prefers BP. and for that reason leronlimab may never be approved. even after 10 years
i agree that NIH will favor BP. and for that reason cytodyn will likely never get future NIH funding. even if the drug is great

the drug works. that doesn;t matter. this is an investment board. you own stock in cytodyn. cytodyn is a terrible investment because it is nearly impossible for biotechs to get approvals on their own and cytodyn is in an almost impossible position to ever gain a partner. they are in a deep financial morass. they aren't running trials. they need 10 years of pinpoint accurate execution to perhaps gain any approval. share price could languish most of that time. potential catalysts are few. you have MD Anderson preclinical results (unknown time frame) and functional cure preclinical results (2026) as top notch potential catalysts. anything else is minor and/or extremely unlikely.